catechin has been researched along with globotriaosylceramide in 1 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 1 (100.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Choi, SR; Kim, GY; Lee, CM; Lee, HJ; Moon, DO; Park, YM | 1 |
1 other study(ies) available for catechin and globotriaosylceramide
Article | Year |
---|---|
Epigallocatechin-3-gallate suppresses galactose-alpha1,4-galactose-1beta,4-glucose ceramide expression in TNF-alpha stimulated human intestinal epithelial cells through inhibition of MAPKs and NF-kappaB.
Topics: Apoptosis; Blotting, Western; Catechin; Cell Nucleus; Cell Proliferation; Dose-Response Relationship, Drug; Epithelial Cells; Flow Cytometry; Galactosyltransferases; Gene Expression Regulation, Enzymologic; Glucosyltransferases; HT29 Cells; Humans; Intestinal Mucosa; Mitogen-Activated Protein Kinases; NF-kappa B; Phosphorylation; Protein Transport; Reverse Transcriptase Polymerase Chain Reaction; RNA, Messenger; Trihexosylceramides; Tumor Necrosis Factor-alpha | 2005 |